Elite Pharmaceuticals, Inc.
ELTP
$0.53
$0.010.95%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 178.57% | 158.56% | 59.23% | 42.59% | 10.41% |
| Total Receivables | 90.60% | 76.79% | 50.14% | 15.27% | 104.32% |
| Inventory | 28.24% | 39.95% | 25.60% | 40.72% | -6.96% |
| Prepaid Expenses | 6.98% | 25.75% | 86.26% | 13.83% | -63.33% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 89.42% | 80.40% | 44.30% | 29.32% | 30.42% |
|
|
|||||
| Total Current Assets | 89.42% | 80.40% | 44.30% | 29.32% | 30.42% |
| Net Property, Plant & Equipment | -6.13% | -6.50% | -3.50% | 31.68% | 46.09% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -37.32% | -34.59% | -15.59% | 6.85% | 9.29% |
| Total Assets | 32.94% | 26.74% | 15.22% | 21.50% | 24.72% |
|
|
|||||
| Total Accounts Payable | 72.67% | 95.20% | 8.96% | 102.04% | -45.05% |
| Total Accrued Expenses | 11.38% | -30.76% | -28.27% | -72.96% | -52.66% |
| Short-term Debt | -- | -- | 0.00% | 0.00% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -5.04% | -6.55% | 6.05% | 202.78% | 288.43% |
| Total Finance Division Other Current Liabilities | -38.05% | 6.06% | -30.58% | 3,770.68% | 3,156.39% |
| Total Other Current Liabilities | -38.05% | 6.06% | -30.58% | 3,770.68% | 3,156.39% |
| Total Current Liabilities | -16.96% | -23.20% | -9.27% | -23.33% | -32.63% |
|
|
|||||
| Total Current Liabilities | -16.96% | -23.20% | -9.27% | -23.33% | -32.63% |
| Long-Term Debt | -7.52% | -7.11% | -7.52% | -7.97% | -8.31% |
| Short-term Debt | -- | -- | 0.00% | 0.00% | 0.00% |
| Capital Leases | -25.59% | -20.95% | -18.56% | 1,395.52% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 82.22% | 420.84% | 299.76% | 498.72% | 584.14% |
| Total Liabilities | 35.99% | 115.09% | 64.45% | 92.03% | 59.73% |
|
|
|||||
| Common Stock & APIC | 0.23% | 0.14% | 0.14% | 4.82% | 5.16% |
| Retained Earnings | 10.98% | -9.34% | -3.71% | -15.02% | -5.30% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | 30.29% | -18.14% | -7.06% | -21.48% | 4.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.29% | -18.14% | -7.06% | -21.48% | 4.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.29% | -18.14% | -7.06% | -21.48% | 4.82% |
|
|
|||||